1. United States of America. Food and Drug Administration. Fact sheet for health care providers emergency use authorization (EUA) of Regen-Covtm (casirivimab and imdevimab) [Internet]. White Oak: FDA; 2021 [cited 2022 June 07]. Available from: https://www.fda.gov/media/145611/download.
2. United States of America. Centers for Disease Control and Prevention. Key updates for week 47, ending November 21, 2020 [Internet]. COVIDView. CDC; 2020 [cited 2022 Jun 07]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/pdf/covidview-11-30-2020.pdf.
3. Kaiser Family Foundation. This week in coronavirus: November 6 to November 12 [Internet]. KFF; 2020 [cited 2022 Jun 07]. Available from: https://www.kff.org/policy-watch/this-week-in-coronavirus-november-6-to-november-12/.
4. Edwards E. A “godsend” or not “worth the effort”? Monoclonal antibodies divide overwhelmed Covid doctors [Internet]. NBC News; 2020 [cited 2021 Aug 06]. Available from: https://www.nbcnews.com/health/health-news/godsend-or-not-worth-effort-monoclonal-antibodies-divide-overwhelmed-covid-n1251684.
5. Collier KL, Colarossi LG, Sanders K. Raising awareness of pre-exposure prophylaxis (PrEP) among women in new york city: community and provider perspectives. J Health Commun. 2017;22(3):183–9.